Abbott Laboratories Earnings

Abbott Laboratories’s revenue jumped 6.9% since last year same period to $11369Mn in the Q3 2025. On a quarterly growth basis, Abbott Laboratories has generated 2.04% jump in its revenue since last 3-months.

Abbott Laboratories’s net profit fell -0.12% since last year same period to $1644Mn in the Q3 2025. On a quarterly growth basis, Abbott Laboratories has generated -7.59% fall in its net profits since last 3-months.

Abbott Laboratories’s net profit margin fell -6.57% since last year same period to 14.46% in the Q3 2025. On a quarterly growth basis, Abbott Laboratories has generated -9.43% fall in its net profit margins since last 3-months.

Abbott Laboratories’s earning per share (EPS) estimates for the current quarter stand at 1.3 - a 31.31% jump from last quarter’s estimates.

Abbott Laboratories’s earning per share (EPS) estimates for the current year stand at 1.3.

Abbott Laboratories’s earning per share (EPS) fell -11.4% since last year same period to 1.01 in the Q2 2025. This indicates that the Abbott Laboratories has generated -11.4% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Abbott Laboratories declared 0.59 dividend per share during the earnings announcement for Q2 2025.